Functional Assessment Screening Patient Reported Information
FAST-PRI
1 other identifier
interventional
666
1 country
1
Brief Summary
This study will evaluate a new tool, based on our currently implemented "Functional Assessment Screening Tablets (FAST)," and activate patients to partner with their physicians. Completion of this project, FAST-PRI, will provide important information on the effectiveness of using HIT patient feedback to inform and activate patients and promote health behavior change. Aim 1 Hypotheses: Patients who receive self-management support through HIT patient feedback (intervention) will be more likely than patients who do not receive such feedback (control) to:
- Initiate discussions with their provider regarding study-designated PRI;
- Have discussions with their providers, regardless of the initiator, regarding study-designated PRI; and
- Perceive these discussions of study-designated PRI to be useful. Approach: We will conduct a 12-month randomized controlled trial of HIT patient feedback, clustered at the physician level, in an academic group medical practice. Patients and providers will complete questionnaires regarding discussions of health behaviors and HRQoL at each clinical encounter. Aim 2 Hypotheses: HIT patient feedback will result in: 1) increased number of smoking quit attempts, 2) increased physical activity, and 3) improved mental HRQoL at six, and twelve months. Approach: Patient participants will complete questionnaires regarding smoking quit attempts, physical activity, and their mental HRQoL at baseline, six and twelve months. Aim 3 Hypotheses: For each study-designated PRI, patients who receive HIT patient feedback will: 1) receive more treatment recommendations (e.g., nurse educator, pharmacist, social worker referrals); 2) act on more treatment recommendations; and 3) exhibit improved self-efficacy regarding their ability to make positive lifestyle changes and improve their HRQoL; physicians whose patients receive HIT patient feedback will have higher self-efficacy regarding their ability to influence their patients to make positive lifestyle changes and improve HRQoL. These, in addition to discussions (Aim 1), will mediate the relationship between HIT patient feedback and improvements in study-designated PRI. Approach: We will survey patients and physicians and abstract referral data from the electronic medical record (EMR).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable quality-of-life
Started Feb 2013
Typical duration for not_applicable quality-of-life
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2012
CompletedFirst Posted
Study publicly available on registry
August 21, 2012
CompletedStudy Start
First participant enrolled
February 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedDecember 2, 2015
December 1, 2015
2.5 years
August 14, 2012
December 1, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Aim 1 Primary outcome: Patient report of differences in the rates of initiation of discussions of PRI in the intervention vs. control group.
The investigators will survey patients and physicians and abstract referral data from the electronic medical record (EMR).
One year
Aim 2 Primary outcome: number of smoking quit attempts, physical activity, and mental HRQoL at six- and twelve-months.
Patient participants will be contacted and asked to report smoking quit attempts, physical activity using the Modified Activity Questionnaire, physical activity lapses, and HRQoL using the RAND-36. Smoking quit attempts will be measured using questions modified from the Tobacco Use Supplement to the Current Population Survey, National Health and Nutrition Examination Survey, and the National Health Interview Survey.
One year
Secondary Outcomes (2)
Aim 1 Secondary outcomes include patient-report of the occurrence of discussion and helpfulness of the discussion and physician reports of initiation, occurrence, and helpfulness of the discussion.
One year
Aim 2 Secondary outcome: percentage of patients being non-smokers, percentage of patients being adequately physically active, and mental HRQoL at twelve months.
One year
Study Arms (4)
Activated Patients
ACTIVE COMPARATORWill use HIT patient feedback to activate patients.
Control patients
OTHERPatients will not receive HIT patient feedback.
Intervention Physicians
OTHERWill use HIT patient feedback to activate patients.
Control Physicians
OTHERPatients will not receive HIT patient feedback.
Interventions
After completing the FAST, GIMO patients seeing a participating provider will receive(or not receive)HIT patient feedback, based on their providers' study group assignment. Feedback for each PRI will be personalized based on the medical history, family history, and other PRI reported on the FAST. A discussion of potential treatment options will be presented along with possible general referral resources. The patient will be encouraged to discuss the PRI with his or her physician. Patients will be provided with a list of resources, customized to their study-designated PRI, that includes ongoing programs available both in the community and GIMO to help them with behavior change and mental HRQoL.
After completing the FAST (standard of care in GIMO) GIMO patients seeing a participating provider will receive (or not receive) HIT patient feedback, based on their providers' study group assignment.
Eligibility Criteria
You may qualify if:
- Physicians will be eligible to participate if:
- They see patients in the GIMO practice and
- They consent to participate in FAST-PRI.
- Patients will be eligible to participate if:
- They are 18 years or older,
- Complete a FAST questionnaire at that visit,
- Have at least one study-designated PRI (i.e.,
- Tobacco use,
- Physical inactivity, or
- Poor mental HRQoL (MHC≤38))
- Consent to participate, and
- Speak English. FAST is only available in English.
You may not qualify if:
- Physicians will be ineligible to participate if:
- They are planning to leave the practice during the study period or
- See patients fewer than 4 hours/week.
- Patients will be ineligible to participate if:
- They are planning to relocate during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
General Internal Medicine
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hess Rachel, MD, MS
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2012
First Posted
August 21, 2012
Study Start
February 1, 2013
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
December 2, 2015
Record last verified: 2015-12